These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28151955)

  • 41. Epidemiologic characteristics, clinical manifestations, and risk factors of 139 patients with Ebola virus disease in western Sierra Leone.
    Xu Z; Jin B; Teng G; Rong Y; Sun L; Zhang J; Du N; Liu L; Su H; Yuan Y; Chen H
    Am J Infect Control; 2016 Nov; 44(11):1285-1290. PubMed ID: 27317404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ebola Virus Outbreak Investigation, Sierra Leone, September 28-November 11, 2014.
    Lu HJ; Qian J; Kargbo D; Zhang XG; Yang F; Hu Y; Sun Y; Cao YX; Deng YQ; Su HX; Dafae F; Sun Y; Wang CY; Nie WM; Bai CQ; Xia ZP; Liu K; Kargbo B; Gao GF; Jiang JF
    Emerg Infect Dis; 2015 Nov; 21(11):1921-7. PubMed ID: 26485317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The 2014 Ebola virus disease outbreak in Pujehun, Sierra Leone: epidemiology and impact of interventions.
    Ajelli M; Parlamento S; Bome D; Kebbi A; Atzori A; Frasson C; Putoto G; Carraro D; Merler S
    BMC Med; 2015 Nov; 13():281. PubMed ID: 26607790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea.
    Vernet MA; Reynard S; Fizet A; Schaeffer J; Pannetier D; Guedj J; Rives M; Georges N; Garcia-Bonnet N; Sylla AI; Grovogui P; Kerherve JY; Savio C; Savio-Coste S; de Séverac ML; Zloczewski P; Linares S; Harouna S; Abdoul BM; Petitjean F; Samake N; Shepherd S; Kinda M; Koundouno FR; Joxe L; Mateo M; Lecine P; Page A; Tchamdja TM; Schoenhals M; Barbe S; Simon B; Tran-Minh T; Longuet C; L'Hériteau F; Baize S
    JCI Insight; 2017 Mar; 2(6):e88864. PubMed ID: 28352651
    [No Abstract]   [Full Text] [Related]  

  • 45. Ebola Virus Disease, Democratic Republic of the Congo, 2014.
    Nanclares C; Kapetshi J; Lionetto F; de la Rosa O; Tamfun JJ; Alia M; Kobinger G; Bernasconi A
    Emerg Infect Dis; 2016 Sep; 22(9):1579-86. PubMed ID: 27533284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ebola Virus Disease Outbreak in Isiro, Democratic Republic of the Congo, 2012: Signs and Symptoms, Management and Outcomes.
    Kratz T; Roddy P; Tshomba Oloma A; Jeffs B; Pou Ciruelo D; de la Rosa O; Borchert M
    PLoS One; 2015; 10(6):e0129333. PubMed ID: 26107529
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of the MSF triage system, separating patients into different wards pending Ebola virus laboratory confirmation, Kailahun, Sierra Leone, July to September 2014.
    Vogt F; Fitzpatrick G; Patten G; van den Bergh R; Stinson K; Pandolfi L; Squire J; Decroo T; Declerck H; Van Herp M
    Euro Surveill; 2015; 20(50):. PubMed ID: 26727011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study.
    Faye O; Andronico A; Faye O; Salje H; Boëlle PY; Magassouba N; Bah EI; Koivogui L; Diallo B; Diallo AA; Keita S; Konde MK; Fowler R; Fall G; Cauchemez S; Sall AA
    PLoS Med; 2015 Dec; 12(12):e1001908. PubMed ID: 26625118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of Ebola virus disease prediction scores: Screening tools for Ebola suspects at the triage-point during an outbreak.
    Tshomba AO; Mukadi-Bamuleka DR; De Weggheleire A; Tshiani OM; Kitenge RO; Kayembe CT; Jacobs BKM; Lynen L; Mbala-Kingebeni P; Muyembe-Tamfum JJ; Ahuka-Mundeke S; Mumba DN; Tshala-Katumbay DD; Mulangu S
    PLoS One; 2022; 17(12):e0278678. PubMed ID: 36525443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Symptom- and Laboratory-Based Ebola Risk Scores to Differentiate Likely Ebola Infections.
    Oza S; Sesay AA; Russell NJ; Wing K; Boufkhed S; Vandi L; Sebba SC; Cummings R; Checchi F
    Emerg Infect Dis; 2017 Nov; 23(11):1792-1799. PubMed ID: 29047428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis of predictive symptoms for Ebola virus disease.
    Jain V; Charlett A; Brown CS
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008799. PubMed ID: 33095771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Indicators for Ebola Patient Survival.
    Crowe SJ; Maenner MJ; Kuah S; Erickson BR; Coffee M; Knust B; Klena J; Foday J; Hertz D; Hermans V; Achar J; Caleo GM; Van Herp M; Albariño CG; Amman B; Basile AJ; Bearden S; Belser JA; Bergeron E; Blau D; Brault AC; Campbell S; Flint M; Gibbons A; Goodman C; McMullan L; Paddock C; Russell B; Salzer JS; Sanchez A; Sealy T; Wang D; Saffa G; Turay A; Nichol ST; Towner JS
    Emerg Infect Dis; 2016 Feb; 22(2):217-23. PubMed ID: 26812579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea.
    Loubet P; Palich R; Kojan R; Peyrouset O; Danel C; Nicholas S; Conde M; Porten K; Augier A; Yazdanpanah Y
    Am J Trop Med Hyg; 2016 Dec; 95(6):1362-1367. PubMed ID: 27928085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of ebola virus disease.
    Kilgore PE; Grabenstein JD; Salim AM; Rybak M
    Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mortality among PCR negative admitted Ebola suspects during the 2014/15 outbreak in Conakry, Guinea: A retrospective cohort study.
    Ingelbeen B; Bah EI; Decroo T; Balde I; Nordenstedt H; van Griensven J; De Weggheleire A
    PLoS One; 2017; 12(6):e0180070. PubMed ID: 28665950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
    Boisen ML; Cross RW; Hartnett JN; Goba A; Momoh M; Fullah M; Gbakie M; Safa S; Fonnie M; Baimba F; Koroma VJ; Geisbert JB; McCormick S; Nelson DK; Millett MM; Oottamasathien D; Jones AB; Pham H; Brown BL; Shaffer JG; Schieffelin JS; Kargbo B; Gbetuwa M; Gevao SM; Wilson RB; Pitts KR; Geisbert TW; Branco LM; Khan SH; Grant DS; Garry RF
    J Infect Dis; 2016 Oct; 214(suppl 3):S203-S209. PubMed ID: 27521365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful Control of Ebola Virus Disease: Analysis of Service Based Data from Rural Sierra Leone.
    Lokuge K; Caleo G; Greig J; Duncombe J; McWilliam N; Squire J; Lamin M; Veltus E; Wolz A; Kobinger G; de la Vega MA; Gbabai O; Nabieu S; Lamin M; Kremer R; Danis K; Banks E; Glass K
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004498. PubMed ID: 26959413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential Impact of Sexual Transmission on Ebola Virus Epidemiology: Sierra Leone as a Case Study.
    Abbate JL; Murall CL; Richner H; Althaus CL
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004676. PubMed ID: 27135922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.
    Dunning J; Sahr F; Rojek A; Gannon F; Carson G; Idriss B; Massaquoi T; Gandi R; Joseph S; Osman HK; Brooks TJ; Simpson AJ; Goodfellow I; Thorne L; Arias A; Merson L; Castle L; Howell-Jones R; Pardinaz-Solis R; Hope-Gill B; Ferri M; Grove J; Kowalski M; Stepniewska K; Lang T; Whitehead J; Olliaro P; Samai M; Horby PW;
    PLoS Med; 2016 Apr; 13(4):e1001997. PubMed ID: 27093560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EBOLA Ag K-SeT rapid test: field evaluation in Sierra Leone.
    Colavita F; Biava M; Mertens P; Gilleman Q; Borlon C; Delli Guanti M; Petrocelli A; Cataldi G; Kamara AT; Kamara SA; Konneh K; Vincenti D; Castilletti C; Abdurahman S; Mirazimi A; Capobianchi MR; Ippolito G; Miccio R; Di Caro A
    Clin Microbiol Infect; 2018 Jun; 24(6):653-657. PubMed ID: 29107122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.